Author:
Gray Joshua P.,Ray Sidhartha D.
Reference130 articles.
1. Cardiovascular function and treatment in beta-thalassemia major: a consensus statement from the American Heart Association;Pennell;Circulation,2013
2. Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassemia: a meta-analysis of 16 randomized controlled trials;Xia;PLoS One,2013
3. Evaluation and treatment of transfusional iron overload in children;Ware;Pediatr Clin North Am,2013
4. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload;Piga;Haematologica,2006
5. Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients;Mourad;Br J Haematol,2003
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metal Antagonists and Metals;Side Effects of Drugs Annual;2018